Search research articles
Contact Us
Filters
Showing results (31-40 of 50) with videos related to
Page
of 5
Sort By:
Transfusion
|
July 13, 2020
A multicenter evaluation of heterogeneity in cellular therapy processing laboratory procedure times to assess workload capacity
Suzanne R Thibodeaux, David H McKenna, Zbigniew M Szczepiorkowski, et al.
Transfusion
|
April 29, 2017
Clinical methods of cryopreservation for donor lymphocyte infusions vary in their ability to preserve functional T-cell subpopulations
D Nicole Worsham, Jo-Anna Reems, Zbigniew M Szczepiorkowski, et al.
Cytotherapy
|
April 1, 2020
Variations in novel cellular therapy products manufacturing
Magali J Fontaine, Eileen Selogie, David Stroncek, et al.
Diabetes Technology & Therapeutics
|
November 27, 2002
Continuous measurement of oxygen consumption by pancreatic islets
Ian R Sweet, Gamal Khalil, Angela R Wallen, et al.
Transfusion
|
February 11, 2012
Cryopreservation of umbilical cord blood with a novel freezing solution that mimics intracellular ionic composition
Ian B Nicoud, Dominic M Clarke, Greta Taber, et al.
American Journal of Physiology. Heart and Circulatory Physiology
|
January 21, 2022
Acellular human amniotic fluid protects the ischemic-reperfused rat myocardium
Young Sook Lee, Hadi Javan, Jo-Anna Reems, et al.
Transplantation
|
November 27, 2002
Effect of the two-layer (University of Wisconsin solution-perfluorochemical plus O2) method of pancreas preservation on human islet isolation, as assessed by the Edmonton Isolation Protocol
Shinichi Matsumoto, Sabrina A Qualley, Shilpa Goel, et al.
Frontiers in Cell and Developmental Biology
|
July 3, 2020
Human Mesenchymal Stromal Cell (MSC) Characteristics Vary Among Laboratories When Manufactured From the Same Source Material: A Report by the Cellular Therapy Team of the Biomedical Excellence for Safer Transfusion (BEST) Collaborative
David F Stroncek, Ping Jin, David H McKenna, et al.
Cytotherapy
|
April 1, 2011
Guidelines for the development and validation of new potency assays for the evaluation of umbilical cord blood
Stephen Spellman, Carolyn K Hurley, Colleen Brady, et al.
Transfusion
|
September 12, 2018
Current practices for viability testing of cryopreserved cord blood products: an international survey by the cellular therapy team of the Biomedical Excellence for Safer Transfusion (BEST) Collaborative
Minoko Takanashi, Eileen Selogie, Jo-Anna Reems, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 50) with videos related to
Sort By:
Page
of 5
Transfusion
|
July 13, 2020
A multicenter evaluation of heterogeneity in cellular therapy processing laboratory procedure times to assess workload capacity
Suzanne R Thibodeaux, David H McKenna, Zbigniew M Szczepiorkowski, et al.
Transfusion
|
April 29, 2017
Clinical methods of cryopreservation for donor lymphocyte infusions vary in their ability to preserve functional T-cell subpopulations
D Nicole Worsham, Jo-Anna Reems, Zbigniew M Szczepiorkowski, et al.
Cytotherapy
|
April 1, 2020
Variations in novel cellular therapy products manufacturing
Magali J Fontaine, Eileen Selogie, David Stroncek, et al.
Diabetes Technology & Therapeutics
|
November 27, 2002
Continuous measurement of oxygen consumption by pancreatic islets
Ian R Sweet, Gamal Khalil, Angela R Wallen, et al.
Transfusion
|
February 11, 2012
Cryopreservation of umbilical cord blood with a novel freezing solution that mimics intracellular ionic composition
Ian B Nicoud, Dominic M Clarke, Greta Taber, et al.
American Journal of Physiology. Heart and Circulatory Physiology
|
January 21, 2022
Acellular human amniotic fluid protects the ischemic-reperfused rat myocardium
Young Sook Lee, Hadi Javan, Jo-Anna Reems, et al.
Transplantation
|
November 27, 2002
Effect of the two-layer (University of Wisconsin solution-perfluorochemical plus O2) method of pancreas preservation on human islet isolation, as assessed by the Edmonton Isolation Protocol
Shinichi Matsumoto, Sabrina A Qualley, Shilpa Goel, et al.
Frontiers in Cell and Developmental Biology
|
July 3, 2020
Human Mesenchymal Stromal Cell (MSC) Characteristics Vary Among Laboratories When Manufactured From the Same Source Material: A Report by the Cellular Therapy Team of the Biomedical Excellence for Safer Transfusion (BEST) Collaborative
David F Stroncek, Ping Jin, David H McKenna, et al.
Cytotherapy
|
April 1, 2011
Guidelines for the development and validation of new potency assays for the evaluation of umbilical cord blood
Stephen Spellman, Carolyn K Hurley, Colleen Brady, et al.
Transfusion
|
September 12, 2018
Current practices for viability testing of cryopreserved cord blood products: an international survey by the cellular therapy team of the Biomedical Excellence for Safer Transfusion (BEST) Collaborative
Minoko Takanashi, Eileen Selogie, Jo-Anna Reems, et al.
Page
of 5